<DOC>
	<DOCNO>NCT02617628</DOCNO>
	<brief_summary>This study collaboration University Pennsylvania , Philadelphia Prison System , North East Treatment Center ( NETSteps ) . It purpose study impact injectable opiate addiction medication ( extended release naltrexone ) give reentry community might help improve reconnection healthcare support system , possibly help reduce recidivism .</brief_summary>
	<brief_title>Outcomes Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone</brief_title>
	<detailed_description>The primary objective study offer tool support improve healthcare relate outcomes reduce risk relapse recidivism opiate addict prisoner reentering community release correctional facility . In study investigator examine medication-assisted therapy ( extended release naltrexone ) likely acceptable correctional facility opioid addict prisoner improve outcome achieve usual detoxification/treatment referral approach . The result may used facilitate policy change involve add extend release naltrexone correctional facility formulary use reentry , collaborate one outpatient treatment provider maintain continuity care . Two hundred ( 200 ) opioid addict prisoner currently incarcerate Philadelphia Prison System , meet study admission criterion express interest extend release naltrexone treatment , give informed consent schedule release within 14 day randomize study enrol . These 200 subject stratify sex ( male/females ) , 18 year old , sentence ) .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Opioid dependent physiological feature accord Diagnostic Statistical Manual Mental Disorders5th edition Interested extend release naltrexone treatment Eligible health benefit reinstate Detoxified able pas naloxone challenge ( e.g . withdrawal within 30 minute receive 0.8 mg naloxone I.M . document score &lt; 5 Clinical Opiate Withdrawal Scale Age 18 Not transfer serve longer sentence State Federal prison Provide address phone number along name contact information 3 person likely know reach permission contact unable reach way Able speak read English provide inform consent able correctly answer 9 10 study quiz item pregnant agree use acceptable form birth control access NET Steps via car public transportation reentry Planning move Philadelphia area within next 6 month Neurological , cardiovascular , renal , hepatic ( Alanine aminotransferase , Aspartate aminotransferase Gammaglutamyl transpeptidase &gt; 3 time top limit normal ) another medical disorder seriously impairs make hazardous ability participate Active tuberculosis Currently psychotic , homicidal , suicidal Uncontrolled seizure disorder History allergy naltrexone , polylactidecoglycolide , carboxymethylcellulose , component diluent Chronic pain opioids need Sentenced naltrexone Treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>opioid addiction</keyword>
</DOC>